Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunovant Inc (NQ: IMVT ) 30.70 -0.20 (-0.63%) Streaming Delayed Price Updated: 3:14 PM EDT, Sep 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Immunovant Inc < Previous 1 2 3 4 5 Next > Lamb Weston, SP Plus And Other Big Stocks Moving Higher On Thursday October 05, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review September 29, 2023 But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. Via Investor's Business Daily What's Going On Pfizer's Subsidiary Biohaven Stock? September 27, 2023 Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an Via Benzinga Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 27, 2023 Gainers Via Benzinga Where Immunovant Stands With Analysts September 18, 2023 Via Benzinga Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29% September 27, 2023 The companies hope by lowering immunoglobulin G, an antibody, that they can treat myriad autoimmune diseases. Via Investor's Business Daily Why Immunovant Stock Is Bolting Higher Today September 27, 2023 The company may have best-in-class autoimmune disease therapy under its roof. Via The Motley Fool Immunovant Parlays Its Shot At Rivaling Argenx Into A $300 Million Offering September 27, 2023 Both companies are working on drugs that lower an antibody tied to numerous autoimmune conditions. Via Investor's Business Daily MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday September 27, 2023 U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst September 27, 2023 Roivant Sciences has 12 drugs in its pipeline. The company’s Immunovant subsidiary reported strong results for its drug. Roivant is in talks with Roche to sell its Chron’s disease for $7 billion. Via Talk Markets What 11 Analyst Ratings Have To Say About Immunovant August 16, 2023 Via Benzinga 9 Analysts Have This to Say About Immunovant July 18, 2023 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Immunovant: Here's What You Need To Know May 23, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 September 27, 2023 Via Benzinga Why Shares of Immunovant Are Soaring on Tuesday September 26, 2023 Immunovant sees strong potential for an autoimmune disorder therapy. Via The Motley Fool Nasdaq Down 1.5%; Immunovant Shares Spike Higher September 26, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P... Via Benzinga Topics Stocks Exposures US Equities Analyst Expectations for Immunovant's Future May 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 26, 2023 Via Benzinga Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 26, 2023 Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... Via Benzinga Crude Oil Moves Higher; Cintas Earnings Top Estimates September 26, 2023 U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday September 26, 2023 U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today? September 26, 2023 Immunovant Inc (NASDAQ: IMVT), a unit of Roivant Sciences Ltd (NASDAQ: ROIV), announced that subcutaneously administered doses of IMVT-1402 produced dose-dependent reductions in Immunoglobulin G (IgG)... Via Benzinga These 2 Biotech Stocks Are Bucking a Down Market Tuesday September 26, 2023 Stock index futures pointed to a lower open on Wall Street Tuesday morning. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 26, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday September 26, 2023 Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors! Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session September 18, 2023 Via Benzinga If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now August 25, 2023 Roivant stock has outperformed the broader market and the biotech sector this year, mirroring the rise in the fortunes of its founder Vivek Ramaswamy. Via Benzinga Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development July 18, 2023 Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 17, 2023 It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday! Via InvestorPlace Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session July 17, 2023 U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.